ResMed data shows GLP-1 users use CPAP more
Is it time to buy ResMed (ASX: RMD)? Well, the company is having good momentum right now - it delivered another strong…
AnteoTech Slides on $3.5m Raise as Dilution Fears Hit
AnteoTech (ASX: ADO) dropped 14.2 per cent on Tuesday to A$0.018 after announcing a A$3.5 million capital raise at a steep…
